---
title: "Fortis Healthcare Ltd (FORTIS) — Share Price, Financials & Analysis"
symbol: "FORTIS"
company: "Fortis Healthcare Ltd"
canonical: "https://tapetide.com/stocks/FORTIS"
isin: "INE061F01013"
nse_symbol: "FORTIS"
bse_code: "532843"
sector: "Healthcare Services"
industry: "Hospitals"
market_cap_cr: 67055.38
generated_at: "2026-09-13T19:02:43.293Z"
---

# Fortis Healthcare Ltd (FORTIS)

Canonical page: https://tapetide.com/stocks/FORTIS

## Company

- **NSE Symbol:** FORTIS
- **BSE Code:** 532843
- **ISIN:** INE061F01013
- **Sector:** Healthcare Services
- **Industry:** Hospitals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2007-05-09
- **CEO:** Dr. Ashutosh Raghuvanshi
- **Employees:** 12237
- **Face Value:** ₹10
- **F&O Eligible:** Yes
- **Website:** fortishealthcare.com

## About

FHL was incorporated in February 1996. The company’s first healthcare facility became operational in Mohali, Punjab in 2001. It is a leading integrated healthcare service provider in India. The healthcare verticals of the company primarily comprise hospitals, diagnostics and day care specialty facilities. Currently, the company operates its healthcare delivery services in India, Nepal, Dubai and Sri Lanka with 36 healthcare facilities with approximately 4,000 operational beds. [1]
Company controls its diagnostics business through its 57% owned subsidiary SRL Limited. It is amongst the largest private diagnostics chains. It has a presence in over 600 cities and towns, with an established strength of 415 laboratories, 8,200 direct clients and 1,400 Collection Centers. [2]

## Latest Price

- **Price:** ₹887.8
- **Change:** -14.65 (-1.62%)
- **Open:** ₹897.5
- **Day High:** ₹900
- **Day Low:** ₹885
- **Previous Close:** ₹902.45
- **Volume:** 784589
- **As Of:** 2026-09-11T10:29:28+00:00

## Key Fundamentals

Observed at 2026-09-11T04:31:03.164640Z.

- **Market Cap:** ₹67055.38 Cr
- **Classification:** Midcap
- **P/E (reported):** 63.6
- **P/E (TTM):** 63.96
- **EPS (TTM):** ₹13.88
- **EPS (reported):** ₹8.5
- **Book Value:** ₹131.07
- **Price to Book:** 6.88
- **Dividend Yield:** 0.11%
- **ROE:** 10.47%
- **ROCE:** 12.13%
- **Debt to Equity:** 0.35
- **Revenue (yearly):** ₹9178.5 Cr
- **Net Income:** ₹1064.2 Cr
- **EBITDA:** ₹2135.6 Cr
- **52-Week High:** ₹1104.3
- **52-Week Low:** ₹766.8
- **RSI (14):** 42.68

## Tapetide Score

- **Score:** 40 / 100
- **Score date:** 2026-09-04
- **Archetype:** Weak and Under Pressure
- **What it means:** Weak financials are the defining feature, and neither the valuation nor the trend reading is strong enough to offset them. Worth reading the risk flags and recent filings closely before anything else.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Falling
- **Percentile:** 14.5 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 35.27 | 9% |
| growth | 51.94 | 9% |
| momentum | 17.37 | 12% |
| ownership | 48.24 | 24% |
| quality | 45.82 | 22% |
| valuation | 35.64 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company has delivered good profit growth of 64.3% CAGR over last 5 years

### Weaknesses

- Stock is trading at 6.77 times its book value
- Company has a low return on equity of 9.87% over last 3 years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 12.47% | 45.57% | 85.06% |
| ebitda margin growth | 6.62% | 10.39% | 23.51% | 21.96% |
| net income growth | 0.59% | 31.48% | 27% | 64% |
| revenue growth | 8.34% | 16.93% | 13% | 18% |
| roce | 8.6% | 23.02% | 24.16% | 10.2% |
| roe | 0.59% | 18.57% | 8.95% | -7.1% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 1770 | 1680 | 1786 | 1859 | 1988 | 1928 | 2007 | 2167 | 2331 | 2265 | 2365 | 2545 |
| Expenses | 1440 | 1396 | 1405 | 1516 | 1554 | 1553 | 1572 | 1676 | 1775 | 1759 | 1832 | 2008 |
| Operating Profit | 330 | 284 | 381 | 343 | 435 | 375 | 435 | 491 | 556 | 506 | 532 | 537 |
| OPM % | 19 | 17 | 21 | 18 | 22 | 19 | 22 | 23 | 24 | 22 | 23 | 21 |
| Other Income | 18 | 19 | 17 | 14 | -42 | 47 | -29 | 31 | 50 | -34 | -2 | 28 |
| Interest | 32 | 33 | 35 | 35 | 36 | 45 | 68 | 70 | 75 | 86 | 84 | 80 |
| Depreciation | 84 | 87 | 92 | 91 | 95 | 97 | 102 | 101 | 106 | 120 | 122 | 122 |
| Profit before tax | 233 | 183 | 271 | 230 | 261 | 279 | 237 | 351 | 425 | 266 | 324 | 363 |
| Tax % | 21 | 27 | 25 | 24 | 26 | 9 | 21 | 24 | 23 | 26 | 16 | 25 |
| Net Profit | 184 | 134 | 203 | 174 | 193 | 254 | 188 | 267 | 329 | 197 | 271 | 273 |
| EPS in Rs | 2.3 | 1.78 | 2.37 | 2.2 | 2.34 | 3.28 | 2.44 | 3.45 | 4.26 | 2.57 | 3.52 | 3.53 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 4561 | 4469 | 4632 | 4030 | 5718 | 6298 | 6893 | 7783 | 9128 | 9506 |
| Expenses | 4287 | 4238 | 4022 | 3626 | 4649 | 5196 | 5625 | 6195 | 7043 | 7375 |
| Operating Profit | 274 | 231 | 610 | 404 | 1069 | 1101 | 1268 | 1588 | 2085 | 2131 |
| OPM % | 6 | 5 | 13 | 10 | 19 | 17 | 18 | 20 | 23 | 22 |
| Other Income | -689 | 228 | 126 | 95 | 367 | 157 | 64 | -11 | 45 | 42 |
| Interest | 258 | 337 | 205 | 166 | 147 | 129 | 131 | 184 | 314 | 325 |
| Depreciation | 239 | 233 | 292 | 291 | 301 | 316 | 342 | 386 | 449 | 470 |
| Profit before tax | -912 | -110 | 239 | 43 | 988 | 814 | 858 | 1007 | 1366 | 1378 |
| Tax % | 2 | 103 | 62 | 230 | 20 | 22 | 25 | 20 | 22 | — |
| Net Profit | -934 | -224 | 91 | -56 | 790 | 633 | 645 | 809 | 1064 | 1070 |
| EPS in Rs | -19.46 | -3.96 | 0.77 | -1.45 | 7.35 | 7.8 | 7.93 | 10.26 | 13.8 | 13.88 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 13 | 13 | 10 | 7 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 518 | 519 | 755 | 755 | 755 | 755 | 755 | 755 | 755 | 755 |
| Reserves | 4626 | 3543 | 5846 | 5906 | 5365 | 5423 | 6487 | 6908 | 8162 | 9141 |
| Borrowings | 2217 | 1962 | 2010 | 1594 | 1531 | 1255 | 926 | 1155 | 2475 | 3473 |
| Other Liabilities | 2227 | 2455 | 2875 | 2781 | 3216 | 4082 | 3921 | 4153 | 1985 | 2465 |
| Total Liabilities | 9588 | 8479 | 11486 | 11036 | 10866 | 11516 | 12089 | 12971 | 13377 | 15833 |
| Fixed Assets | 5419 | 4992 | 8477 | 8802 | 8799 | 9416 | 9426 | 9874 | 10424 | 12230 |
| CWIP | 268 | 226 | 450 | 204 | 165 | 193 | 228 | 542 | 407 | 434 |
| Investments | 1878 | 1732 | 270 | 175 | 186 | 104 | 210 | 230 | 169 | 243 |
| Other Assets | 2023 | 1529 | 2290 | 1856 | 1716 | 1803 | 2225 | 2326 | 2378 | 2926 |
| Total Assets | 9588 | 8479 | 11486 | 11036 | 10866 | 11516 | 12089 | 12971 | 13377 | 15833 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 966 | 493 | -179 | 172 | 485 | 865 | 822 | 1100 | 1424 | 1601 |
| Cash from Investing Activity | -1001 | -333 | -3279 | 63 | -131 | -501 | -372 | -889 | -780 | -1537 |
| Cash from Financing Activity | 259 | -672 | 4257 | -862 | -143 | -517 | -471 | -86 | -714 | 164 |
| Net Cash Flow | 225 | -513 | 799 | -627 | 212 | -153 | -21 | 125 | -70 | 228 |
| Free Cash Flow | 689 | 437 | -261 | 35 | 274 | 750 | 367 | 172 | 591 | 673 |
| CFO/OP | 304 | 187 | 30 | 84 | 108 | 101 | 100 | 104 | 97 | 90 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 38 | 38 | 44 | 36 | 41 | 33 | 34 | 33 | 37 | 42 |
| Inventory Days | 23 | 24 | 22 | 30 | 29 | 33 | 31 | 24 | 23 | 24 |
| Days Payable | 215 | 279 | 296 | 226 | 205 | 178 | 179 | 164 | 161 | 165 |
| Cash Conversion Cycle | -155 | -217 | -230 | -161 | -135 | -112 | -115 | -107 | -101 | -99 |
| Working Capital Days | -87 | -113 | -234 | -150 | -56 | -35 | -22 | -124 | -30 | -34 |
| ROCE % | 11 | 3 | 6 | 4 | 2 | 10 | 10 | 10 | 12 | 13 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 31.17% | 31.17% | 31.17% | 31.17% | 31.17% | 31.17% | 31.17% | 31.17% | 31.17% | 31.17% | 31.17% | 31.17% |
| FIIs | 26.32% | 23.72% | 23.24% | 23.31% | 25.26% | 26.77% | 27.4% | 27.17% | 27.9% | 27.84% | 25.97% | 25.2% |
| DIIs | 26.55% | 29.35% | 31.15% | 32.31% | 30.73% | 30.05% | 29.46% | 29.79% | 29.14% | 29.33% | 31.35% | 32.23% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 11.13% | 11.04% | 10.82% | 10.47% | 10.36% | 10.21% | 10.22% | 10.17% | 10.14% | 10.14% | 9.96% | 9.87% |
| Others | 4.83% | 4.72% | 3.63% | 2.75% | 2.48% | 1.81% | 1.75% | 1.7% | 1.65% | 1.53% | 1.54% | 1.53% |
| No. of Shareholders | 131516 | 135664 | 157165 | 154260 | 204184 | 221750 | 218329 | 205373 | 220766 | 233156 | 226685 | 220743 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 2 / 5 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 908.27 | Sell |
| EMA (10) | 906.89 | Sell |
| SMA (20) | 912.08 | Sell |
| EMA (20) | 913.17 | Sell |
| SMA (50) | 933.32 | Sell |
| EMA (50) | 926.09 | Sell |
| SMA (100) | 945.87 | Sell |
| EMA (100) | 928.57 | Sell |
| SMA (200) | 912.39 | Sell |
| EMA (200) | 907.34 | Sell |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 37.89 | Neutral |
| MACD (12,26,9) | -8.34 | Sell |
| Stochastic (14,3,3) | 23.26 | Neutral |
| ADX (14) | 7.27 | Neutral |
| Williams %R (14) | -95.08 | Buy |
| ATR (14) | 18.75 | Neutral |
| ROC (12) | -2.85 | Sell |
| Stoch RSI (14) | 0 | Buy |
| UO (7,14,28) | 49.85 | Neutral |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 15 | 88.24% |
| Hold | 2 | 11.76% |
| Sell | 0 | 0% |

Based on 17 analyst ratings, observed at 2026-09-11T04:58:24.323749+00:00.

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 8 Apr - Reported private placement debt securities outstanding as of March 31, 2026: ₹1,550 crore across three issuances. | [Compliances-Half Yearly Report (SEBI Circular No. CIR/IMD/DF-1/67/2017) 8 Apr - Reported private placement debt securities outstanding as of March 31, 2026: ₹1,550 crore across three issuances.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/054f925c-6e57-419b-a6be-d2f427279b0d.pdf) |
| 8 Apr - Fortis filed Regulation 74(5) certificates for quarter ended March 31, 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 8 Apr - Fortis filed Regulation 74(5) certificates for quarter ended March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b2b3f139-fc2c-4214-8a3b-26676d19532a.pdf) |
| 29 Apr - Tokyo District Court proceedings on NTK claim concluded; judgment scheduled for 10 September 2026. | [Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 ('SEBI Listing Regulations') Regarding A Material Litigation Filed By Northern TK Venture Pte Ltd. ('NTK'), The Promoter Shareholder Of The Company, Against Daiichi Sankyo Company Limited Before The Tokyo District Court In Japan. 29 Apr - Tokyo District Court proceedings on NTK claim concluded; judgment scheduled for 10 September 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/38b81a26-b49e-40d5-8ccd-39ad1c0b00c0.pdf) |
| 29 Apr - Tokyo District Court proceedings on NTK claim concluded; judgment scheduled for 10 September 2026. | [Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 ('SEBI Listing Regulations') Regarding A Material Litigation Filed By Northern TK Venture Pte Ltd. ('NTK'), The Promoter Shareholder Of The Company, Against Daiichi Sankyo Company Limited Before The Tokyo District Court In Japan. 29 Apr - Tokyo District Court proceedings on NTK claim concluded; judgment scheduled for 10 September 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/38b81a26-b49e-40d5-8ccd-39ad1c0b00c0.pdf) |
| 28 Mar - Income Tax order dated 27-Mar-2026 demands INR 117.04 Crore from Fortis Hospitals (wholly-owned subsidiary). | [Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 (SEBI Listing Regulations)- Income Tax Order For Wholly Owned Subsidiary 28 Mar - Income Tax order dated 27-Mar-2026 demands INR 117.04 Crore from Fortis Hospitals (wholly-owned subsidiary).](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f9381dbd-b6d7-437d-94df-3b73835a70f6.pdf) |
| 23 Apr - Fortis Healthcare approved grant of up to 1.32 crore ESOPs on April 23, 2026 at ₹923.10 each. | [Intimation Of Grant Of Employee Stock Options ('Options') Under 'Fortis Healthcare Limited Employee Stock Option Scheme 2026." 23 Apr - Fortis Healthcare approved grant of up to 1.32 crore ESOPs on April 23, 2026 at ₹923.10 each.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/217ca4ee-20b9-4877-9593-8eca03b1506b.pdf) |
| 22 Apr - Fortis Healthcare schedules non-deal investor roadshow in Mumbai on 27-28 April 2026. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 22 Apr - Fortis Healthcare schedules non-deal investor roadshow in Mumbai on 27-28 April 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5c416acc-40b8-45b2-8803-34e9be5e55b8.pdf) |
| 2 Mar - Merger: FESL, FCCL, FHMEL, B&B merged into Fortis Hospitals; effective March 1, 2026. | [Effective Date Of Scheme Of Arrangement- Merger By Absorption 2 Mar - Merger: FESL, FCCL, FHMEL, B&B merged into Fortis Hospitals; effective March 1, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/93eba530-c312-4f27-b9cf-56c3a4ee8894.pdf) |
| 19 Feb - NTK filed amended claim (12 Feb 2026) vs Daiichi Sankyo seeking INR109.3bn damages and injunction. | [Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 ('SEBI Listing Regulations') Regarding A Material Litigation Filed By Northern TK Venture Pte Ltd. ('NTK'), The Promoter Shareholder Of The Company, Against Daiichi Sankyo Company Limited Before The Tokyo District Court In Japan. 19 Feb - NTK filed amended claim (12 Feb 2026) vs Daiichi Sankyo seeking INR109.3bn damages and injunction.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5d1be4c7-f124-4db7-ad3a-db822d44bfb9.pdf) |
| 18 Mar - Fortis approved Employees Stock Option Scheme 2026 and grants to subsidiary/associate employees; passed March 18, 2026. | [Approval Of Employee Stock Option Scheme 2026 By Shareholders. 18 Mar - Fortis approved Employees Stock Option Scheme 2026 and grants to subsidiary/associate employees; passed March 18, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4104f070-c8b6-44d2-8a29-f4283d76bc1b.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-09-10 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=75cc9d36-7c45-4fd2-97f6-b586b422f7fa.pdf) |
| 2026-08-11 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a7b2d38-f8ae-424b-b5ff-810655ac8278.pdf) |
| 2026-05-29 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11cc6af4-e63e-4f6b-84b7-a6f3a478ec08.pdf) |
| 2026-02-20 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=76a1f65a-3975-401f-af1f-29858affadb7.pdf) |
| 2025-11-17 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cdfba045-0ae4-47f5-a584-f374baa3aac7.pdf) |
| 2025-08-11 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3f1a4279-7aea-4798-b490-7543e1ec6b8b.pdf) |
| 2025-05-26 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9e8bfd3f-3a89-43c2-b5d4-101255e962d6.pdf) |
| 2025-02-14 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=edc28ce3-514e-46f3-858f-aa69776dce9f.pdf) |
| 2025-02-14 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5c340d45-18b2-4aaa-9c0c-c1ccb91cb23b.pdf) |
| 2024-11-13 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4150b9a8-589b-4a7e-894c-6b92d1dec111.pdf) |

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-09 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=17c6bc3d-d8bb-4433-b0db-d54a14a58fe4.pdf) |
| 2026-09-09 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d0a1f26f-c4e9-48d5-8426-5958e8446997.pdf) |
| 2026-09-09 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ff7c39f0-fd95-4646-a1ff-cd22004e3f96.pdf) |
| 2026-09-09 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6bb493d3-ffff-4374-ae21-d2e76fd008a7.pdf) |
| 2026-09-04 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f4df69ee-9566-48a8-a157-81fb66ebb4f4.pdf) |
| 2026-09-01 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2f66b633-8afd-465c-ac9c-1302d023a1ef.pdf) |
| 2026-09-01 | [Announcement Under Regulation 30 (LODR) - Regarding Order Passed By The HonBle Delhi High Court In Relation To Certain Applications Filed By Daiichi Sankyo Company Limited Inter Alia The Company. Detailed Disclosure Is Attached.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=86bf5a15-2a7e-4f94-bc6e-ed43e1ecae7e.pdf) |
| 2026-08-24 | [ESG Rating](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cb291fd0-f057-4334-8989-e7447183b41b.pdf) |
| 2026-08-11 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b5985cd8-89b8-4ca1-b454-721c21fcfff9.pdf) |
| 2026-08-11 | [Summary Of The Proceedings Of The 30Th Annual General Meeting.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6a0657e4-072e-45b9-b6a0-ac53beef4e66.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-06 | [Financial Results Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7926a139-af92-407a-9994-73b6ab8b525a.pdf) |
| 2026-05-22 | [Financial Results For The Quarter And Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=09f454ea-46ac-4f40-a26c-dbdf9ee371d7.pdf) |
| 2026-02-13 | [Outcome Of The Board Meeting-13-02-2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=01413f3c-c861-489a-95e3-ab495b3f7cfd.pdf) |
| 2025-11-11 | [UN-Audited Financial Results For The Quarter Ended September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=55402ff1-6966-41be-bd6b-9529b98b1138.pdf) |
| 2025-08-06 | [Outcome Of The Board Meeting Under Regulation 30 33 Regulation 51(2) And 52 Of Securities Andexchange Board Of India (Listing Obligations & Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d0eea001-903e-4769-b69f-d895b58311ac.pdf) |
| 2025-05-20 | [Outcome Of The Board Meeting Under Regulation 30 33 51(2) And Regulation 52 Of Securities And Exchange Board Of India (Listing Obligations & Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=18a246e4-0908-4af9-8406-e5c65a8861f8.pdf) |
| 2025-02-07 | [Outcome Of The Board Meeting Under Regulation 30 And Regulation 51(2) And 52 Of Securities And Exchange Board Of India (Listing Obligations & Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0aeb9d0a-ec2b-4d8b-b13c-369714cc99ec.pdf) |
| 2024-11-08 | [Un-Audited Financial Results For Half Year Ended September 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e198151f-489a-4773-9770-d3897907d063.pdf) |
| 2024-08-06 | [Financial Results For The Quarter Ended June 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5ef125d6-6ad4-4f02-acdb-e746e679cb5d.pdf) |
| 2024-08-06 | [Results For The Quarter Ended June 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=79c619d5-bc4d-4ea4-8e55-668e49b91943.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-08-06 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=38d8754f-0838-4124-b105-a528a75871c3.pdf) |
| 2026-05-22 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a87c688c-86e3-434f-a1ad-fb944bbaf8c3.pdf) |
| 2026-02-13 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a9c442e9-1769-4392-95d1-0b668818e1b5.pdf) |
| 2026-01-08 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=843f3f26-ee30-4760-aa3f-3b602bc394dc.pdf) |
| 2025-11-11 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=95ff9771-5ddc-4195-ab24-5b780061471b.pdf) |
| 2025-08-06 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=96e81bcf-2790-42e7-81a2-70c27c190224.pdf) |
| 2025-05-20 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=772e56fb-bccb-4c78-abc4-49b3c78d5440.pdf) |
| 2025-02-07 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c5e714e4-3457-4d20-890a-7bdf03c989a2.pdf) |
| 2024-11-08 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=70605f4f-b342-4f29-afce-dc2900013226.pdf) |
| 2024-08-06 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c702204d-154b-4d42-998b-2d68ef905d0a.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cdfba045-0ae4-47f5-a584-f374baa3aac7.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4150b9a8-589b-4a7e-894c-6b92d1dec111.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c7f85cdc-0919-4eef-bfdf-83702d7a48be.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c7f85cdc-0919-4eef-bfdf-83702d7a48be.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1acfd411-2ec0-4dbe-9e24-b3c51b003158.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/11cc6af4-e63e-4f6b-84b7-a6f3a478ec08.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/11cc6af4-e63e-4f6b-84b7-a6f3a478ec08.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a87c688c-86e3-434f-a1ad-fb944bbaf8c3.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/a87c688c-86e3-434f-a1ad-fb944bbaf8c3.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9e8bfd3f-3a89-43c2-b5d4-101255e962d6.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/80e836f9-7a41-4d29-bf51-ce3cdf10da5a.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/21ea29d4-a646-4a13-bc57-30dae1857ca0.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/73f68210-36a4-4e18-a6c8-6a6df5386a7c.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2025-05-21 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ce5789e9-24f0-4554-97d9-d98c1dcff239.pdf) |
| 2024-11-09 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e80a46d4-84be-4019-b2fe-1c84b744c709.pdf) |
| 2024-08-07 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f1622c20-ba99-4e4b-8b56-04343eb027a7.pdf) |
| 2024-05-26 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0300091b-5c71-4454-be9e-3c4ba97f53c8.pdf) |
| 2024-02-10 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bbc44638-1019-4e90-b053-0a19ac80781f.pdf) |
| 2023-11-11 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f23af7b7-c026-41a0-be47-d0a866246397.pdf) |
| 2023-08-07 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=965b67b1-0b78-412f-ba93-6e6b0a2b73b4.pdf) |
| 2023-05-25 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fe729d9d-7d96-4df6-b242-5b966527bc79.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:02:43.293Z.